More than one million Americans have received vaccines against coronavirus, developed by Pfizer, a US company, and its German partner BioNTech, as well as American Moderna. This was reported by the Center for Disease Control and Prevention (CDC).
As many as 1,008,025 people have been vaccinated, with 9.4 million doses of the drug ready to be administered at this time. There are 328.2 million people in the United States.
This “small but important milestone” has been reached by the country in 10 days. “A limited amount of COVID-19 vaccine is now available in the U.S., but supplies will increase in the coming weeks and months. The goal is to make it easy for everyone to get vaccinated as soon as enough vaccine is available,” experts said.
The first coronavirus vaccination was given in the United States on Dec. 14. The drug was given to New York nurse Sandra Lindsay, who has been working with COVID-19 patients for the past ten months. Two days earlier, President Donald Trump announced the start of the vaccination and called the drug against COVID-19 one of the greatest scientific advances in history.
So far, there are several vaccines against COVID-19 in the world. Thus, two vaccines have been registered in Russia: Sputnik V and EpiVacCorona. On December 5, vaccination against coronavirus with Sputnik V started in Moscow. A COVID-19 vaccine produced by Pfizer/BioNTech and another developed by Moderna have been registered in the United States. Also, the British pharmaceutical company AstraZeneca announced the start of clinical trials of a combination of its AZD1222 vaccine.
As of Dec. 24, there were more than 78.4 million people worldwide infected with the coronavirus, of whom more than 1.72 million had died and another 44.2 million had recovered. The U.S., India, Brazil, Russia and France have the most infections.